These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20116265)

  • 1. Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands.
    Bezouska K; Snajdrová R; Krenek K; Vancurová M; Kádek A; Adámek D; Lhoták P; Kavan D; Hofbauerová K; Man P; Bojarová P; Kren V
    Bioorg Med Chem; 2010 Feb; 18(4):1434-40. PubMed ID: 20116265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic N-acetyl-D-glucosamine based fully branched tetrasaccharide, a mimetic of the endogenous ligand for CD69, activates CD69+ killer lymphocytes upon dimerization via a hydrophilic flexible linker.
    Kovalová A; Ledvina M; Saman D; Zyka D; Kubícková M; Zídek L; Sklenár V; Pompach P; Kavan D; Bílý J; Vanek O; Kubínková Z; Libigerová M; Ivanová L; Antolíková M; Mrázek H; Rozbeský D; Hofbauerová K; Kren V; Bezouska K
    J Med Chem; 2010 May; 53(10):4050-65. PubMed ID: 20433142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between subunits is essential for high-affinity binding of N-acetyl-D-hexosamines to dimeric soluble and dimeric cellular forms of human CD69.
    Kavan D; Kubícková M; Bílý J; Vanek O; Hofbauerová K; Mrázek H; Rozbeský D; Bojarová P; Kren V; Zídek L; Sklenár V; Bezouska K
    Biochemistry; 2010 May; 49(19):4060-7. PubMed ID: 20369839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440].
    Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors.
    Drozdová A; Bojarová P; Křenek K; Weignerová L; Henssen B; Elling L; Christensen H; Jensen HH; Pelantová H; Kuzma M; Bezouška K; Krupová M; Adámek D; Slámová K; Křen V
    Carbohydr Res; 2011 Sep; 346(12):1599-609. PubMed ID: 21641586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of multivalent glycoconjugates containing the immunoactive LELTE peptide: effect of glycosylation on cellular activation and natural killing by human peripheral blood mononuclear cells.
    Renaudet O; Krenek K; Bossu I; Dumy P; Kádek A; Adámek D; Vanek O; Kavan D; Gazák R; Sulc M; Bezouska K; Kren V
    J Am Chem Soc; 2010 May; 132(19):6800-8. PubMed ID: 20420392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation.
    Lin CR; Wei TY; Tsai HY; Wu YT; Wu PY; Chen ST
    FASEB J; 2015 Dec; 29(12):5006-17. PubMed ID: 26296369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression kinetics of CD69 molecule by CD3⁺ lymphocytes and γδT cells under three different activating modalities].
    Wang K; Hou Y; Wang X; Han G
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):753-4. PubMed ID: 25152129
    [No Abstract]   [Full Text] [Related]  

  • 10. Trifluoperazine reduces the expression of CD69 in phytohemagglutinin-activated lymphocytes.
    Pires V; Harab RC; Rumjanek VM
    Braz J Med Biol Res; 1996 Apr; 29(4):479-83. PubMed ID: 8736111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Early Activation Marker CD69 on Peripheral Blood Lymphocytes from Pregnant Women after First Trimester Alloimmunization.
    Krechetova LV; Vtorushina VV; Nikolaeva MA; Golubeva EL; Van'ko LV; Saribegova VA; Tetruashvili NK
    Bull Exp Biol Med; 2016 Aug; 161(4):529-32. PubMed ID: 27591871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of CD69 targeting on bystander and antigen-specific T cell proliferation.
    Alari-Pahissa E; Vega-Ramos J; Zhang JG; Castaño AR; Turley SJ; Villadangos JA; Lauzurica P
    J Leukoc Biol; 2012 Jul; 92(1):145-58. PubMed ID: 22544938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis-specific polyfunctional cytotoxic CD8+ T cells express CD69.
    Li L; Yang B; Zhang X; Lao S; Changyou Wu
    Tuberculosis (Edinb); 2014 May; 94(3):219-25. PubMed ID: 24566284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors.
    Sancho D; Santis AG; Alonso-Lebrero JL; Viedma F; Tejedor R; Sánchez-Madrid F
    J Immunol; 2000 Oct; 165(7):3868-75. PubMed ID: 11034393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood natural killer cells activation status determined by CD69 upregulation predicts implantation outcome in IVF.
    Dons'koi BV; Chernyshov VP; Sirenko VY; Strelko GV; Osypchuk DV
    Immunobiology; 2014 Mar; 219(3):167-71. PubMed ID: 24157280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation.
    Kimura MY; Hayashizaki K; Tokoyoda K; Takamura S; Motohashi S; Nakayama T
    Immunol Rev; 2017 Jul; 278(1):87-100. PubMed ID: 28658550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new therapeutic target: the CD69-Myl9 system in immune responses.
    Kimura MY; Koyama-Nasu R; Yagi R; Nakayama T
    Semin Immunopathol; 2019 May; 41(3):349-358. PubMed ID: 30953160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69.
    Zhou X; Zhang P; Luo W; Zhang L; Hu R; Sun Y; Jiang H
    Cancer Med; 2018 Mar; 7(3):788-795. PubMed ID: 29453833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is CD69 an effective brake to control inflammatory diseases?
    González-Amaro R; Cortés JR; Sánchez-Madrid F; Martín P
    Trends Mol Med; 2013 Oct; 19(10):625-32. PubMed ID: 23954168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of activation antigen CD69 on eosinophils].
    Morii T; Nishikawa K; Ako H; Narita N
    Nihon Rinsho; 1993 Mar; 51(3):588-92. PubMed ID: 8492431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.